Platelet dysfunction--differentiation of a newly recognized primary type from that produced by aspirin.
D000227:Adenine Nucleotides / Q000378:metabolism / Q000494:pharmacology; D000328:Adult; D001241:Aspirin / Q000009:adverse effects*; D001778:Blood Coagulation Disorders / Q000175:diagnosis; D001780:Blood Coagulation Tests; D001791:Blood Platelet Disorders / Q000139:chemically induced / Q000175:diagnosis*; D001792:Blood Platelets / Q000187:drug effects / Q000378:metabolism; D001803:Blood Transfusion; D002498:Centrifugation; D003094:Collagen / Q000494:pharmacology; D003937:Diagnosis, Differential; D004837:Epinephrine / Q000494:pharmacology; D005260:Female; D005898:Glass; D006474:Hemorrhagic Disorders / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged; D012459:Salicylates / Q000097:blood / Q000652:urine; D012701:Serotonin / Q000494:pharmacology; D013917:Thrombin / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology; D014842:von Willebrand Diseases / Q000175:diagnosis
D000227:Adenine Nucleotides; D012459:Salicylates; D012701:Serotonin; D003094:Collagen; D014357:Trypsin; D013917:Thrombin; D001241:Aspirin; D004837:Epinephrine